Procedural sedation with dexmedetomidine during ablation of atrial fibrillation: A randomized controlled trial

Europace

Volumn 16, Issue 7, 2014, Pages 994-999

  Sairaku, Akinori ^a,b   Yoshida, Yukihiko ^a   Hirayama, Haruo ^a   Nakano, Yukiko ^b   Ando, Monami ^a   Kihara, Yasuki ^b  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Ablation of atrial fibrillation; Dexmedetomidine; Patient movement; Respiratory disturbance index

Indexed keywords

DEXMEDETOMIDINE; GABAERGIC RECEPTOR AFFECTING AGENT; SEDATIVE AGENT; THIAMYLAL; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; HYPNOTIC SEDATIVE AGENT;

ADULT; APNEA; APNEA MONITORING; ARTICLE; BODY MOVEMENT; BRADYCARDIA; CATHETER ABLATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT MOBILITY; PRIORITY JOURNAL; PULMONARY AND AIRWAY FUNCTION ANALYZER; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; RESPIRATORY DISTURBANCE INDEX; SEDATION; SLEEP DISORDERED BREATHING; AGED; ATRIAL FIBRILLATION; BREATHING; CHEMICALLY INDUCED; COMPARATIVE STUDY; CONSCIOUS SEDATION; DRUG EFFECTS; JAPAN; MIDDLE AGED; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PATIENT MONITORING; PROCEDURES; RISK FACTOR; SLEEP; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; AGED; ATRIAL FIBRILLATION; BRADYCARDIA; CATHETER ABLATION; CONSCIOUS SEDATION; DEXMEDETOMIDINE; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; HYPOTENSION; JAPAN; LINEAR MODELS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; RESPIRATION; RISK FACTORS; SLEEP; THIAMYLAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 84903975569     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut363     Document Type: Article

References (18)

1. Hummel JD, Elsayed-Awad H. Walking the tightrope between deep sedation and general anesthesia: By whom can this safely be done?. J Cardiovasc Electrophysiol 2011;22:1344-5
2. de Bono J. Propofol: A safe drug for physician-led procedures?. Europace 2012;14: 303-5
3. SalukheTV, Willems S, Drewitz I, Steven D, Hoffmann BA, HeitmannKet al. Propofol sedation administered by cardiologists without assisted ventilation for long cardiac interventions: An assessment of 1000 consecutive patients undergoing atrial fibrillation ablation. Europace 2012;14:325-30
4. Perel A. Non-anaesthesiologists should not be allowed to administer propofol for procedural sedation: A Consensus Statement of 21 European National Societies of Anaesthesia. Eur J Anaesthesiol 2011;28:580-4
5. Hoy SM, Keating GM. Dexmedetomidine: A review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs 2011;71:1481-501
6. Keating GM, Hoy SM, Lyseng-Williamson KA. Dexmedetomidine: A guide to its use for sedation in the US. Clin Drug Investig 2012;32:561-7
7. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, WisemandleW, Koura F et al. Dexmedetomidine vs. midazolam for sedation of critically ill patients: A randomized trial. JAMA 2009;301:489-99
8. Candiotti KA, Bergese SD, Bokesch PM, Feldman MA, WisemandleW, Bekker AY et al. Monitored anesthesia care with dexmedetomidine: A prospective, randomized, double-blind, multicenter trial. Anesth Analg 2010;110:47-56
9. Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ et al.; Dexmedetomidine for Long-Term Sedation Investigators. Dexmedetomidine vs. midazolam or propofol for sedation during prolonged mechanical ventilation: Two randomized controlled trials. JAMA 2012;307:1151-60
10. Kobayashi M, Namba K, Tsuiki S, Nakamura M, Hayashi M, Mieno Y et al. Validity of sheet-type portable monitoring device for screening obstructive sleep apnea syndrome. Sleep Breath 2013;17:589-95
11. Sairaku A, Yoshida Y, Hirayama H, Nakano Y, Nanasato M, Kamiya H et al. Clinical significance of sleep-disordered breathing induced by sedatives during ablation of atrial fibrillation. Sleep Med 2013;14:622-7
12. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al. 2012 HRS/ EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528-606
13. JohnsMW.Anewmethod for measuring daytime sleepiness: TheEpworth sleepiness scale. Sleep 1991;14:540-5
14. Sessler CN, Gosnell MS, Grap MJ, BrophyGM, O'Neal PV, Keane KA et al. The Richmond Agitation-Sedation Scale: Validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002;166:1338-44
15. Ouyang F, Antz M, Ernst S, Hachiya H, Mavrakis H, Deger FT et al. Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: Lessons from double Lasso technique. Circulation 2005;111:127-35
16. Ryu JH, LeeSW, Lee JH, Lee EH, Do SH, Kim CS. Randomized double-blind study of remifentanil and dexmedetomidine for flexible bronchoscopy. Br J Anaesth 2012; 108:503-11
17. Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP et al. Clinical guideline for the evaluation, management and long-termcare of obstructive sleep apnea in adults. J Clin Sleep Med 2009;5:263-76
18. Clutton-Brock J. Pain and the barbiturates. Anaesthesia 1961;16:80-8